
Liver Cancer Diagnostics Market by Test Type (Biopsy, Endoscopy, Imaging), End User (Academic & Research Institutes, Hospitals & Diagnostic Laboratories, Pharmaceutical & CRO Laboratories) - Global Forecast 2024-2030
Description
Liver Cancer Diagnostics Market by Test Type (Biopsy, Endoscopy, Imaging), End User (Academic & Research Institutes, Hospitals & Diagnostic Laboratories, Pharmaceutical & CRO Laboratories) - Global Forecast 2024-2030
The Liver Cancer Diagnostics Market size was estimated at USD 9.41 billion in 2023 and expected to reach USD 10.05 billion in 2024, at a CAGR 6.62% to reach USD 14.74 billion by 2030.
Global Liver Cancer Diagnostics Market
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Liver Cancer Diagnostics Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Liver Cancer Diagnostics Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Liver Cancer Diagnostics Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Accuray Incorporated, Biocartis NV, C.R. Bard Inc., Elekta AB, Epigenomics AG, F. Hoffmann-La Roche Ltd., Fujifilm Medical Systems U.S.A., Inc., Illumina, Inc., Koninklijke Philips N.V., Myriad Genetics, Inc., Qiagen N.V., Siemens AG, Sysmex Corporation, and Thermo Fisher Scientific, Inc..
Market Segmentation & Coverage
This research report categorizes the Liver Cancer Diagnostics Market to forecast the revenues and analyze trends in each of the following sub-markets:
Test Type
Biopsy
Endoscopy
Imaging
Laboratory tests
Biomarkers
Enzymes & Isoenzymes
Growth Factors & Receptors
Molecular Markers
Oncofetal & Glycoprotein Antigens
Pathological Biomarkers
Blood Tests
End User
Academic & Research Institutes
Hospitals & Diagnostic Laboratories
Pharmaceutical & CRO Laboratories
Region
Americas
Argentina
Brazil
Canada
Mexico
United States
California
Florida
Illinois
New York
Ohio
Pennsylvania
Texas
Asia-Pacific
Australia
China
India
Indonesia
Japan
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam
Europe, Middle East & Africa
Denmark
Egypt
Finland
France
Germany
Israel
Italy
Netherlands
Nigeria
Norway
Poland
Qatar
Russia
Saudi Arabia
South Africa
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom
The report offers valuable insights on the following aspects:
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
The report addresses key questions such as:
1. What is the market size and forecast of the Liver Cancer Diagnostics Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Liver Cancer Diagnostics Market?
3. What are the technology trends and regulatory frameworks in the Liver Cancer Diagnostics Market?
4. What is the market share of the leading vendors in the Liver Cancer Diagnostics Market?
5. Which modes and strategic moves are suitable for entering the Liver Cancer Diagnostics Market?
Note: PDF & Excel + Online Access - 1 Year
Table of Contents
186 Pages
- 1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Language
- 1.6. Limitations
- 1.7. Assumptions
- 1.8. Stakeholders
- 2. Research Methodology
- 2.1. Define: Research Objective
- 2.2. Determine: Research Design
- 2.3. Prepare: Research Instrument
- 2.4. Collect: Data Source
- 2.5. Analyze: Data Interpretation
- 2.6. Formulate: Data Verification
- 2.7. Publish: Research Report
- 2.8. Repeat: Report Update
- 3. Executive Summary
- 4. Market Overview
- 4.1. Introduction
- 4.2. Liver Cancer Diagnostics Market, by Region
- 5. Market Insights
- 5.1. Market Dynamics
- 5.1.1. Drivers
- 5.1.1.1. Increasing Incidence of liver cancer globally
- 5.1.1.2. Favorable reimbursement framework for liver cancer diagnosis
- 5.1.1.3. Growing number of liver cancer screening programs
- 5.1.2. Restraints
- 5.1.2.1. Limited skilled and trained professionals
- 5.1.3. Opportunities
- 5.1.3.1. Technological advancements in cancer diagnosis equipment
- 5.1.3.2. Focus on development of effective diagnostics
- 5.1.4. Challenges
- 5.1.4.1. Limitations of liver cancer diagnostics
- 5.2. Market Segmentation Analysis
- 5.3. Market Trend Analysis
- 5.4. Cumulative Impact of High Inflation
- 5.5. Porter’s Five Forces Analysis
- 5.5.1. Threat of New Entrants
- 5.5.2. Threat of Substitutes
- 5.5.3. Bargaining Power of Customers
- 5.5.4. Bargaining Power of Suppliers
- 5.5.5. Industry Rivalry
- 5.6. Value Chain & Critical Path Analysis
- 5.7. Regulatory Framework
- 6. Liver Cancer Diagnostics Market, by Test Type
- 6.1. Introduction
- 6.2. Biopsy
- 6.3. Endoscopy
- 6.4. Imaging
- 6.5. Laboratory tests
- 6.6.1. Biomarkers
- 6.6.2.1. Enzymes & Isoenzymes
- 6.6.2.2. Growth Factors & Receptors
- 6.6.2.3. Molecular Markers
- 6.6.2.4. Oncofetal & Glycoprotein Antigens
- 6.6.2.5. Pathological Biomarkers
- 6.6.2. Blood Tests
- 7. Liver Cancer Diagnostics Market, by End User
- 7.1. Introduction
- 7.2. Academic & Research Institutes
- 7.3. Hospitals & Diagnostic Laboratories
- 7.4. Pharmaceutical & CRO Laboratories
- 8. Americas Liver Cancer Diagnostics Market
- 8.1. Introduction
- 8.2. Argentina
- 8.3. Brazil
- 8.4. Canada
- 8.5. Mexico
- 8.6. United States
- 9. Asia-Pacific Liver Cancer Diagnostics Market
- 9.1. Introduction
- 9.2. Australia
- 9.3. China
- 9.4. India
- 9.5. Indonesia
- 9.6. Japan
- 9.7. Malaysia
- 9.8. Philippines
- 9.9. Singapore
- 9.
- 10. South Korea
- 9.
- 11. Taiwan
- 9.
- 12. Thailand
- 9.
- 13. Vietnam
- 10. Europe, Middle East & Africa Liver Cancer Diagnostics Market
- 10.1. Introduction
- 10.2. Denmark
- 10.3. Egypt
- 10.4. Finland
- 10.5. France
- 10.6. Germany
- 10.7. Israel
- 10.8. Italy
- 10.9. Netherlands
- 10.
- 10. Nigeria
- 10.
- 11. Norway
- 10.
- 12. Poland
- 10.
- 13. Qatar
- 10.
- 14. Russia
- 10.
- 15. Saudi Arabia
- 10.
- 16. South Africa
- 10.
- 17. Spain
- 10.
- 18. Sweden
- 10.
- 19. Switzerland
- 10.
- 20. Turkey
- 10.
- 21. United Arab Emirates
- 10.
- 22. United Kingdom
- 11. Competitive Landscape
- 11.1. FPNV Positioning Matrix
- 11.2. Market Share Analysis, By Key Player
- 11.3. Competitive Scenario Analysis, By Key Player
- 12. Competitive Portfolio
- 12.1. Key Company Profiles
- 12.1.1. Abbott Laboratories
- 12.1.2. Accuray Incorporated
- 12.1.3. Biocartis NV
- 12.1.4. C.R. Bard Inc.
- 12.1.5. Elekta AB
- 12.1.6. Epigenomics AG
- 12.1.7. F. Hoffmann-La Roche Ltd.
- 12.1.8. Fujifilm Medical Systems U.S.A., Inc.
- 12.1.9. Illumina, Inc.
- 12.1.
- 10. Koninklijke Philips N.V.
- 12.1.
- 11. Myriad Genetics, Inc.
- 12.1.
- 12. Qiagen N.V.
- 12.1.
- 13. Siemens AG
- 12.1.
- 14. Sysmex Corporation
- 12.1.
- 15. Thermo Fisher Scientific, Inc.
- 12.2. Key Product Portfolio
- 13. Appendix
- 13.1. Discussion Guide
- 13.2. License & Pricing
- FIGURE 1. LIVER CANCER DIAGNOSTICS MARKET RESEARCH PROCESS
- FIGURE 2. LIVER CANCER DIAGNOSTICS MARKET SIZE, 2023 VS 2030
- FIGURE 3. LIVER CANCER DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
- FIGURE 4. LIVER CANCER DIAGNOSTICS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
- FIGURE 5. LIVER CANCER DIAGNOSTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 6. LIVER CANCER DIAGNOSTICS MARKET DYNAMICS
- FIGURE 7. LIVER CANCER DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2023 VS 2030 (%)
- FIGURE 8. LIVER CANCER DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 9. LIVER CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2023 VS 2030 (%)
- FIGURE 10. LIVER CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 11. AMERICAS LIVER CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 12. AMERICAS LIVER CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 13. UNITED STATES LIVER CANCER DIAGNOSTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
- FIGURE 14. UNITED STATES LIVER CANCER DIAGNOSTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 15. ASIA-PACIFIC LIVER CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 16. ASIA-PACIFIC LIVER CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 17. EUROPE, MIDDLE EAST & AFRICA LIVER CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 18. EUROPE, MIDDLE EAST & AFRICA LIVER CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 19. LIVER CANCER DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2023
- FIGURE 20. LIVER CANCER DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2023
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.